Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)

Shenzhen Salubris Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 2, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	34,325	35,644	36,225	30,220	29,138	20,858
Market Cap Growth	16.90%	-1.61%	19.87%	3.71%	39.70%	-4.55%
Enterprise Value	32,532	33,898	33,154	27,017	28,494	20,363
Last Close Price	30.79	32.08	31.81	25.97	26.93	18.47
PE Ratio	56.01	61.45	56.86	56.62	478.73	29.16
Forward PE	51.32	58.32	54.75	27.88	27.77	14.35
PS Ratio	8.75	10.59	10.40	9.88	10.64	4.67
PB Ratio	3.99	4.42	4.54	3.76	5.21	3.13
P/TBV Ratio	5.27	5.33	5.24	4.38	6.98	4.19
P/FCF Ratio	61.16	211.61	97.42	43.02	39.81	19.87
P/OCF Ratio	32.65	42.46	37.31	25.50	21.20	13.84
PEG Ratio	1.15	1.15	1.15	1.15	1.15	1.15
EV/Sales Ratio	8.32	10.07	9.52	8.83	10.40	4.56
EV/EBITDA Ratio	34.04	38.93	37.95	33.84	51.59	19.32
EV/EBIT Ratio	54.77	62.49	58.62	53.57	93.03	24.70
EV/FCF Ratio	57.97	201.24	89.16	38.46	38.93	19.40
Debt / Equity Ratio	0.01	0.01	0.03	0.01	0.07	0.05
Debt / EBITDA Ratio	0.08	0.07	0.24	0.10	0.71	0.33
Debt / FCF Ratio	0.14	0.38	0.56	0.11	0.53	0.33
Asset Turnover	0.40	0.35	0.37	0.38	0.37	0.57
Inventory Turnover	2.33	2.06	2.08	2.00	1.90	1.80
Quick Ratio	2.51	3.40	2.56	3.88	1.49	3.24
Current Ratio	3.72	4.06	2.94	4.35	1.94	3.97
Return on Equity (ROE)	7.42%	7.25%	7.92%	7.75%	0.82%	10.07%
Return on Assets (ROA)	3.78%	3.54%	3.72%	3.90%	2.61%	6.59%
Return on Capital (ROIC)	4.39%	4.16%	4.33%	4.47%	2.95%	7.29%
Earnings Yield	1.79%	1.63%	1.76%	1.77%	0.21%	3.43%
FCF Yield	1.64%	0.47%	1.03%	2.32%	2.51%	5.03%
Dividend Yield	1.64%	1.56%	1.57%	1.54%	-	2.71%
Payout Ratio	89.43%	94.71%	69.25%	2.91%	878.69%	119.23%
Buyback Yield / Dilution	-0.23%	-1.55%	-2.90%	-5.23%	3.55%	-0.26%
Total Shareholder Return	1.41%	0.00%	-1.33%	-3.69%	3.55%	2.45%

Source: S&P Capital IQ. Standard template. Financial Sources.